Hospital Provider’s Perspectives on MOUD Initiation and Continuation After Inpatient Discharge

期刊论文
出版模式：

开放获取
发表日期：

2024年11月25日

查看全文

Riley Shearer,
Honora Englander,
Hildi Hagedorn,
Adetayo Fawole,
JoAn Laes,
Hope Titus,
Alisa Patten,
Emily Oot,
Noa Appleton,
Amy Fitzpatrick,
Roxanne Kibben,
Jasmine Fernando,
Jennifer McNeely,
Dave Gustafson,
Noa Krawczyk,
Zoe Weinstein,
Paulette Baukol,
Udi Ghitza,
Tracy Siegler,
Gavin Bart,
Angela Bazzi

摘要

Background

Individuals with opioid use disorder have high rates of hospital admissions, which represent a critical opportunity to engage patients and initiate medications for opioid use disorder (MOUD). However, few patients receive MOUD and, even if MOUD is initiated in the hospital, patients may encounter barriers to continuing MOUD in the community.

Objective

Describe hospital providers’ experiences and perspectives to inform initiatives and policies that support hospital-based MOUD initiation and continuation in community treatment programs.

Design

As part of a broader implementation study focused on inpatient MOUD (NCT#04921787), we conducted semi-structured interviews with hospital providers.

Participants

Fifty-seven hospital providers from 12 community hospitals.

Approach

Thematic analysis examined an emergent topic on challenges transitioning patients to outpatient MOUD treatment and related impacts on MOUD initiation by inpatient providers.

Key Results

Participants described structural barriers to transitioning hospitalized patients to continuing outpatient MOUD including (a) limited outpatient buprenorphine prescriber availability, (b) the siloed nature of addiction treatment, and (c) long wait times. As a result of observing these structural barriers, participants experienced a sense of futility that deterred them from initiating MOUD. Participants proposed strategies that could better support these patient transitions, including developing partnerships between hospitals and outpatient addiction treatment and supporting in-reach services from community providers.

Conclusions

We identified concerns about inadequate and inaccessible community-based care and transition pathways that discouraged hospital providers from prescribing MOUD. As hospital-based opioid treatment models continue to expand, programmatic and policy strategies to support inpatient transitions to outpatient addiction treatment are needed.

NCT Trial Number

04921787.